1. Home
  2. CDIO vs BQ Comparison

CDIO vs BQ Comparison

Compare CDIO & BQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDIO
  • BQ
  • Stock Information
  • Founded
  • CDIO 2017
  • BQ 2008
  • Country
  • CDIO United States
  • BQ China
  • Employees
  • CDIO N/A
  • BQ N/A
  • Industry
  • CDIO Biotechnology: Commercial Physical & Biological Resarch
  • BQ Other Specialty Stores
  • Sector
  • CDIO Health Care
  • BQ Consumer Discretionary
  • Exchange
  • CDIO Nasdaq
  • BQ Nasdaq
  • Market Cap
  • CDIO 6.4M
  • BQ 7.1M
  • IPO Year
  • CDIO N/A
  • BQ 2020
  • Fundamental
  • Price
  • CDIO $3.63
  • BQ $2.52
  • Analyst Decision
  • CDIO Buy
  • BQ
  • Analyst Count
  • CDIO 1
  • BQ 0
  • Target Price
  • CDIO $60.00
  • BQ N/A
  • AVG Volume (30 Days)
  • CDIO 41.9K
  • BQ 36.2K
  • Earning Date
  • CDIO 08-14-2025
  • BQ 08-26-2025
  • Dividend Yield
  • CDIO N/A
  • BQ N/A
  • EPS Growth
  • CDIO N/A
  • BQ N/A
  • EPS
  • CDIO N/A
  • BQ N/A
  • Revenue
  • CDIO $19,507.00
  • BQ $64,617,102.00
  • Revenue This Year
  • CDIO $1,434.82
  • BQ N/A
  • Revenue Next Year
  • CDIO $4,661.91
  • BQ N/A
  • P/E Ratio
  • CDIO N/A
  • BQ N/A
  • Revenue Growth
  • CDIO N/A
  • BQ N/A
  • 52 Week Low
  • CDIO $3.22
  • BQ $1.62
  • 52 Week High
  • CDIO $53.10
  • BQ $9.89
  • Technical
  • Relative Strength Index (RSI)
  • CDIO 41.96
  • BQ 48.50
  • Support Level
  • CDIO $3.58
  • BQ $2.36
  • Resistance Level
  • CDIO $4.05
  • BQ $2.60
  • Average True Range (ATR)
  • CDIO 0.33
  • BQ 0.25
  • MACD
  • CDIO -0.01
  • BQ -0.04
  • Stochastic Oscillator
  • CDIO 24.74
  • BQ 27.66

About CDIO Cardio Diagnostics Holdings Inc. Common stock

Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.

About BQ Boqii Holding Limited representing

Boqii Holding Ltd operates in the business of selling pet products through online stores. The store provides pet foods, health products, pet grooming products, pet bathing products, pet toys, fish tank, aquatic fertilizer, temperature control equipment, oxygen pump and other related products. Also, the company sells its products through offline channels to pet stores and hospitals.

Share on Social Networks: